Emdeon introduces ICD-10 testing exchange

Emdeon, a Tenn.-based provider of healthcare revenue and payment cycle management and clinical information exchange solutions, unveiled its self-service ICD-10 testing exchange.

The exchange allows providers to submit ICD-10 test claims on Emdeon’s self-service customer service portal and receive claim status feedback, according to the company’s press release. The testing exchange offers: provider submission of an unlimited volume of test claims; claim status feedback to providers of clearinghouse testing results; and aggregation of accepted test claims for payers to use in their testing processes.

No additional software is required and testing services are free for Emdeon provider, channel partner and payer customers, according to Emdeon.

Additional information on ICD-10 testing is available here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.